Every year, millions of families are affected by Alzheimer’s disease—a progressive neurodegenerative disorder that slowly erodes memory, thinking, independence, and quality of life. Today, more than 55 million people worldwide live with dementia, and that number is expected to rise dramatically in the coming decades.
Despite decades of research and billions of dollars invested in drug development, effective treatments remain limited. As a result, increasing attention is being directed toward prevention and the biological factors that may influence long-term brain resilience before significant cognitive decline begins.
One factor receiving increasing scientific attention is lithium.
Although lithium is best known as a medication used in psychiatry, emerging research suggests it may also play a broader role in maintaining brain health. Scientists are increasingly investigating whether lithium may play a broader physiological role in supporting neuronal function, cellular resilience, and healthy cognitive aging.
Why Alzheimer’s Disease Develops
Alzheimer’s disease does not begin when memory problems first appear. The disease process often starts years—or even decades—before symptoms become noticeable.
During this time, abnormal proteins gradually accumulate within the brain. Beta-amyloid proteins form plaques between neurons, while tau proteins form tangles inside nerve cells. Together, these changes disrupt communication between brain cells, impair energy production, trigger inflammation, and ultimately contribute to neuronal loss.
As these processes progress, individuals may experience memory impairment, reduced concentration, personality changes, mood disturbances, and difficulties performing everyday activities.
Because significant brain damage has often occurred before symptoms emerge, many researchers now emphasize the importance of identifying factors that may help preserve neuronal health earlier in life.
Lithium’s Role in Brain Protection
Lithium appears to influence several of the biological pathways involved in cognitive aging and neurodegeneration.
One of its most studied mechanisms involves inhibition of glycogen synthase kinase-3 (GSK-3), an enzyme that plays a central role in both beta-amyloid accumulation and abnormal tau phosphorylation. By helping regulate this pathway, lithium may reduce some of the molecular changes associated with Alzheimer’s disease.
Scientists are increasingly investigating whether lithium may play a broader physiological role in supporting neuronal function, cellular resilience, and healthy cognitive aging. Research also suggests lithium may support production of brain-derived neurotrophic factor (BDNF), a protein involved in neuronal growth, survival, synaptic plasticity, and learning.
BDNF helps neurons survive, form new connections, and adapt to learning and environmental challenges.BDNF plays an important role in maintaining neural adaptability and supporting cognitive function across the lifespan. .
Beyond these effects, lithium appears to influence several interconnected systems involved in healthy brain aging, including inflammation, oxidative stress regulation, mitochondrial function, and synaptic stability.
Lithium, Neuroinflammation, and Cognitive Decline
Scientists increasingly recognize that Alzheimer’s disease is not solely a disorder of protein accumulation. Chronic neuroinflammation is now considered a major driver of disease progression.
When inflammatory signaling remains elevated, immune cells within the brain—known as microglia—can become overactive, contributing to neuronal damage, synaptic dysfunction, and accelerated cognitive decline. Research has shown that these inflammatory processes interact closely with amyloid plaques and tau pathology, creating a cycle that further damages brain tissue.
Studies suggest lithium may influence inflammatory signaling pathways while supporting cellular resilience, mechanisms that may be relevant to long-term brain health and healthy cognitive aging
Emerging Perspectives on Lithium and Cognitive Aging
An important development in lithium research emerged from a 2025 study published in Nature. Researchers discovered that individuals with mild cognitive impairment and Alzheimer’s disease had significantly lower lithium concentrations within brain tissue compared with healthy individuals.
The investigators also reported evidence suggesting that amyloid plaques may sequester lithium, potentially reducing its availability to surrounding neurons. Experimental models showed that lithium depletion was associated with increased neuroinflammation, impaired memory, synaptic dysfunction, and greater neuronal vulnerability.
When trace amounts of lithium were restored, researchers observed improvements in memory performance, reduced inflammatory signaling, and preservation of neural structures throughout the brain.
These findings raise the possibility that altered lithium availability may be more than a consequence of neurodegeneration alone and could play a role in biological processes associated with neuronal vulnerability and cognitive decline. Further research is needed to clarify the direction and significance of this relationship.
Evidence from Human Studies
While mechanistic studies provide important insights, researchers are also examining whether lithium can influence cognitive outcomes in humans.
A 2026 pilot randomized clinical trial involving older adults with mild cognitive impairment found that low-dose lithium was associated with slower decline in verbal memory, particularly among individuals with evidence of underlying Alzheimer’s pathology. Although larger studies are needed, these findings add to a growing body of research suggesting that lithium may support cognitive function during the earliest stages of decline.
Notably, the doses being investigated in these studies are substantially lower than those traditionally used in psychiatric treatment.
Lithium as Part of a Brain-Healthy Lifestyle
No single nutrient can prevent Alzheimer’s disease, and lithium should not be viewed as a cure. Rather, its potential benefits appear most relevant within a comprehensive approach to cognitive health.
Research consistently shows that brain resilience is influenced by multiple lifestyle factors, including:
- Regular physical activity
- High-quality sleep
- Blood sugar regulation
- Social connection
- Cognitive stimulation
- Stress management
- Nutrient-dense dietary patterns such as the Mediterranean diet
Within this broader framework, lithium may represent one factor among many that influence the biological systems involved in neuronal function, neuroplasticity, and healthy aging.
Looking Ahead
Our understanding of lithium’s physiological roles continues to evolve.
Once viewed primarily as a psychiatric medication, lithium is increasingly being investigated as a trace element that may influence several biological processes involved in brain health, including neuroplasticity, inflammation, cellular resilience, and healthy cognitive aging.
While many questions remain unanswered, emerging research suggests that lithium may play a role in the complex systems that help maintain neuronal function and support long-term cognitive health. Importantly, lithium should not be viewed in isolation. Brain aging is shaped by a dynamic interplay of genetics, metabolic health, inflammation, vascular function, lifestyle factors, and environmental influences.
As researchers continue to explore the biological drivers of Alzheimer’s disease and cognitive decline, lithium represents one of many factors being investigated for its potential contribution to brain resilience across the lifespan.
For readers interested in exploring the emerging science and clinical perspectives on nutritional lithium in greater depth, The Lithium Revolution: Balancing Mood, Memory, and Lifelong Brain Health With Nutritional Lithium by Dr. James Greenblatt provides a thoughtful overview of the research and its practical implications.
